Orion Oyj (OTCMKTS:ORINF – Get Free Report)’s share price rose 3.2% during trading on Wednesday . The stock traded as high as $48.65 and last traded at $48.65. Approximately 200 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 1,080 shares. The stock had previously closed at $47.16.
Orion Oyj Stock Up 3.2 %
The stock has a fifty day moving average price of $47.16 and a two-hundred day moving average price of $47.16.
About Orion Oyj
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Featured Articles
- Five stocks we like better than Orion Oyj
- Energy and Oil Stocks Explained
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Following Congress Stock Trades
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Orion Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
